CASI PHARMACEUTICALS, INC. Earnings Per Share (Diluted)
CASI PHARMACEUTICALS, INC. reported Earnings Per Share (Diluted) of -$0.38 per share for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2022-11-14
- CASI PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2022-09-30 was -$0.38.
- CASI PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2022-06-30 was -$0.56.
- CASI PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2022-03-31 was -$0.06.
- CASI PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2021-09-30 was -$0.73.
- CASI PHARMACEUTICALS, INC. earnings per share, diluted for fiscal 2021 was -$0.27.
- CASI PHARMACEUTICALS, INC. earnings per share, diluted for fiscal 2020 was -$0.44.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$0.38 10-Q · filed 2022-11-14 | -$1.57 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | -$0.56 10-Q · filed 2022-08-12 | -$1.19 10-Q · filed 2022-08-12 | ||
| 2022-03-31 | -$0.06 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | -$0.27 10-K · filed 2022-03-28 | |||
| 2021-09-30 | -$0.73 10-Q · filed 2022-11-14 | -$2.30 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | -$0.50 10-Q · filed 2022-08-12 | -$1.57 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | -$0.11 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | -$0.44 10-K · filed 2022-03-28 | |||
| 2019-09-30 | -$349.71 derived: net income ÷ weighted average shares · filed 2020-11-09 | |||
| 2018-09-30 | -$223.52 derived: net income ÷ weighted average shares · filed 2019-11-12 |